denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Integrating New Therapies into the Management of Classical Heme Disorders
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Translational Research, Drug development, Clinical Research, Genetic Disorders, Diseases, Real-world evidence, Treatment Considerations, Adverse Events, Metabolic Disorders, Study Population, Human
Session: Integrating New Therapies into the Management of Classical Heme Disorders
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Translational Research, Drug development, Clinical Research, Genetic Disorders, Diseases, Real-world evidence, Treatment Considerations, Adverse Events, Metabolic Disorders, Study Population, Human
Saturday, December 7, 2024, 2:00 PM-3:15 PM
Disclosures: Dickey: Disc Medicine: Other: Principal Investigator on clinical trial.
OffLabel Disclosure: Much of porphyria treatment is off-label, so I plan to mention some off label uses of both hemin and givosiran
See more of: Integrating New Therapies into the Management of Classical Heme Disorders
See more of: Education Program
See more of: Education Program
<< Previous Presentation
|
Next Presentation